Short-term right heart reverse remodeling with vericiguat in HFrEF: reductions in pulmonary arterial pressure and chamber dimensions
Yaoting Zhang, Chengpeng Zhang, Chao Tang, Hui Li, Jing Zhu · 2026
Read Short-term right heart reverse remodeling with vericiguat in HFrEF: reductions in pulmonary arterial pressure and chamber dimensions by Yaoting Zhang, Chengpeng Zhang, Chao Tang, Hui Li, Jing Zhu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616938.txt.
Description
Yaoting Zhang and four colleagues published a heart failure study in two thousand twenty-six on the drug vericiguat. Most research on the drug covers the heart's left side. This study asked whether it also helps the right side of the heart shrink back toward normal in weakened hearts.
Ninety patients at one Chinese hospital were followed for three months. Sixty took vericiguat and thirty formed a comparison group. In the drug group, a key ratio linking right-side pumping to lung artery pressure rose clearly. The right atrium and right ventricle also measured smaller after treatment. The authors read this as early reverse remodelling of the right heart. They note the study is small and short.
Catalog record
| CREATOR | Yaoting Zhang, Chengpeng Zhang, Chao Tang, Hui Li, Jing Zhu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |